osteomyelitis
Information
- Disease name
- osteomyelitis
- Disease ID
- DOID:1019
- Description
- "A bone inflammation disease that has_material_basis_in infection located_in bone or located_in bone marrow." [url:http\://en.wikipedia.org/wiki/Osteomyelitis, url:http\://my.clevelandclinic.org/disorders/osteomyelitis/hic_osteomyelitis.aspx, url:http\://www.mayoclinic.com/health/osteomyelitis/DS00759, url:http\://www.nlm.nih.gov/medlineplus/ency/article/000437.htm]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04563325 | Active, not recruiting | Phase 4 | Oral-only Antibiotics for Bone and Joint Infections in Children | September 15, 2020 | September 15, 2024 |
| NCT03806166 | Active, not recruiting | N/A | Short or Long Antibiotic Regimes in Orthopaedics | February 21, 2019 | August 7, 2024 |
| NCT03802552 | Completed | Phase 1 | Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections | May 1, 2019 | April 30, 2021 |
| NCT00714402 | Completed | Procalcitonin Level and Kinetics in Children With Bacterial Infections | August 2008 | ||
| NCT01098916 | Completed | N/A | The RAD-HOME Project: a Pilot Study of Domiciliary Teleradiology | June 2008 | June 2009 |
| NCT01336803 | Completed | Phase 2 | Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI | August 2011 | October 2023 |
| NCT03426761 | Completed | Phase 4 | Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections | January 25, 2018 | December 31, 2022 |
| NCT00428844 | Completed | Phase 2 | Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci | June 26, 2007 | June 23, 2010 |
| NCT03380403 | Completed | N/A | A Clinical Trial Testing the Efficacy of PDT in Preventing Amputation in Diabetic Patients | January 1, 2010 | January 1, 2012 |
| NCT03559530 | Completed | Acinetobacter Baumannii-related Osteomyelitis: Clinical and Epidemiological Characterization | May 1, 2017 | December 31, 2019 | |
| NCT05959590 | Completed | Phase 1 | Ferumoxytol-enhanced Imaging of Osteomyelitis | February 12, 2014 | August 12, 2019 |
| NCT02024282 | Completed | N/A | Optimising Diagnosis and Antibiotic Prescribing for Acutely Ill Children in Primary Care | January 2013 | December 2014 |
| NCT02084147 | Completed | N/A | PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases | March 7, 2013 | October 2, 2018 |
| NCT00324922 | Completed | Phase 3 | Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus Osteomyelitis | May 1, 2006 | May 1, 2007 |
| NCT02165579 | Completed | Osteomyelitis: Procalcitonin to Diagnose and Monitor Osteomyelitis | June 2014 | December 2014 | |
| NCT03898219 | Completed | Hematogenous Osteomyelitis in Childhood Can Relapse Dozens of Years in Adulthood | January 1, 2015 | April 6, 2016 | |
| NCT02308774 | Completed | Osteomyelitis: Procalcitonin to Diagnose and Monitor Osteomyelitis (PCT) | August 2014 | October 2015 | |
| NCT02311452 | Completed | Comparative Effectiveness of Intravenous v. Oral Antibiotic Therapy for Serious Bacterial Infections | January 2009 | ||
| NCT02335905 | Completed | Phase 1/Phase 2 | Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children | June 3, 2015 | June 16, 2020 |
| NCT03846804 | Completed | N/A | Next-Generation Sequencing for Pathogen Detection and Quantification in Children With Musculoskeletal Infections | September 1, 2019 | June 2, 2022 |
| NCT02463500 | Completed | UT Southwestern Diabetic Foot Ulcers (DFU) and Osteomyelitis (DFO) Recruitment Database, Data and Tissue Repository | January 2015 | May 2023 | |
| NCT02685033 | Completed | Phase 2 | Study on the Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Participants With Osteomyelitis | March 15, 2016 | December 12, 2017 |
| NCT02736253 | Completed | Risk Factors for Three Critical Stages of the Diabetic Foot Infections | June 2012 | February 2015 | |
| NCT02968693 | Completed | Drug Delivery Devices for Osteomyelitis | April 2011 | July 2016 | |
| NCT00366249 | Completed | Phase 3 | Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis. | January 2007 | March 2009 |
| NCT00402064 | Completed | The Influence of Bisphosphonates in the Oral Cavity in Children | March 2007 | December 2008 | |
| NCT03808285 | Completed | Denosumab Related Osteonecrossi of the Jaw : : an Emergent and Potentially Complex Bone and Joint Infection | January 1, 2013 | December 31, 2018 | |
| NCT06283979 | Not yet recruiting | Phase 2 | A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers. | July 1, 2024 | December 1, 2025 |
| NCT06402292 | Not yet recruiting | N/A | Surgical Treatment of Osteoarticular Infections Using Bioactive Bone Substitute | September 1, 2024 | February 28, 2026 |
| NCT05467644 | Recruiting | Treatment of Fracture Related Infection in Latin America. | January 1, 2021 | December 31, 2023 | |
| NCT02979951 | Recruiting | Fosfomycin i.v. for Treatment of Severely Infected Patients | December 2016 | December 2030 | |
| NCT03012529 | Recruiting | Phase 4 | Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics | January 22, 2018 | September 30, 2024 |
| NCT03594344 | Recruiting | N/A | Additional Hyperbaric Oxygen After Lower Extremity Amputation | July 4, 2018 | December 31, 2025 |
| NCT04538053 | Recruiting | Phase 4 | BonE and Joint Infections - Simplifying Treatment in Children Trial | June 1, 2021 | December 2026 |
| NCT04554108 | Recruiting | N/A | Acute Non-severe Osteomyelitis in Children - Outpatient Management Strategy With Oral Antibiotic Therapy Compared to a Standard Strategy With Conventional Hospitalization and Intravenous Antibiotic Therapy: a Randomized Open-label Non-inferiority Study With Bayesian and Medical-economic Analyses. | May 31, 2021 | May 31, 2025 |
| NCT04936958 | Recruiting | RETR(Osteomyelitis) | May 1, 2023 | May 1, 2025 | |
| NCT05177107 | Recruiting | Phase 2 | Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis | November 24, 2021 | December 2024 |
| NCT05316298 | Recruiting | Diabetic Foot Osteomyelitis Treatment Using Gentamicin-loaded Calcium Sulfate-hydroxyapatite Biocomposite | December 1, 2022 | January 1, 2025 | |
| NCT05713149 | Recruiting | Treatment of Osteomyelitis-associated Pressure Ulcers by Surgical Flaps and Anti-bacterial Agents | February 19, 2023 | February 1, 2027 | |
| NCT06084754 | Recruiting | N/A | Effect of Pulsed Electromagnetic Field Stimulation on Localized Pediatric Osteomyelitis | November 27, 2023 | February 2024 |
| NCT06096012 | Recruiting | Don't Treat Ghosts Anti-MRSA Antibiotics in Osteomyelitis Without Identified MRSA | June 23, 2023 | June 23, 2024 | |
| NCT01612962 | Terminated | Diagnostic Tests to Help Determine Osteomyelitis | May 2011 | February 2015 | |
| NCT03091439 | Terminated | Phase 2 | Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Patients With Osteomyelitis | May 15, 2017 | August 31, 2017 |
| NCT02168816 | Terminated | Phase 2 | Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis | March 19, 2014 | February 2, 2017 |
| NCT02099240 | Terminated | Early Phase 1 | Patients Response to Early Switch To Oral:Osteomyelitis Study | March 6, 2014 | November 7, 2018 |
| NCT02128256 | Unknown status | Phase 4 | CERAMENT™|G - Bone Healing and Re-infection Prophylaxis | May 2014 | May 2017 |
| NCT01137903 | Unknown status | N/A | Efficacy of Surgical Treatment of Osteomyelitis in Diabetic Foot Ulcers | April 2010 | November 2011 |
| NCT04945434 | Unknown status | N/A | Clinical Effectiveness of S53P4 Bioactive Glass in Treatment of Long-bone Chronic Osteomyelitis | September 1, 2011 | June 30, 2021 |
| NCT04141787 | Unknown status | Phase 4 | Ceftriaxone as Home IV for Staph Infections | July 11, 2019 | March 30, 2024 |
| NCT04229511 | Unknown status | Development of Risk Score Model and Decision Tree Algorithm for Predicting Infections With CRKp in Colonized Patients | April 2020 | November 2021 | |
| NCT02005068 | Withdrawn | Phase 4 | Ceftaroline in the Treatment of Bone and Joint Infections | April 2013 | July 2014 |
| NCT02344511 | Withdrawn | Phase 3 | Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis | March 2016 | April 2019 |
| NCT03787862 | Withdrawn | Investigation of the Use of Hyperspectral Imaging in Foot Surgery Patients | June 13, 2014 | June 13, 2015 |
- Disase is a (Disease Ontology)
- DOID:3342
- Cross Reference ID (Disease Ontology)
- GARD:7286
- Cross Reference ID (Disease Ontology)
- ICD9CM:730.1
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:203181001
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0008707
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0002754
- ICD10 preferred id (Insert disease from ICD10)
- D0010773
- ICD10 class code (Insert disease from ICD10)
- M86
- MeSH unique ID (MeSH (Medical Subject Headings))
- D010019